Ganirelix Acetate
NDC 0548-5001, Ganirelix Acetate, injection, from Amphastar Pharmaceuticals, Inc..
- Product NDC
- 0548-5001
- Status
- Listed
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212613
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0548-5001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANIRELIX ACETATE250 ug/.5mL
Pharmacologic classes
Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0548-5001-00 | 00548500100 | 1 SYRINGE in 1 CARTON (0548-5001-00) / .5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9c286f64-8039-44ec-8fdd-d1a2f52b4c3cNADAC price for package 00548500100
GET /v1/drugs/nadac/00548500100
Use it
Look up 0548-5001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0548-5001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0548-5001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.